New IPO: KnowBe4, and Previous IPO Results
A hot time for all IPO investors is still here! I just don’t have time to put everything onto my blog, so will just post a summary here.
The most important thing: we’re having KnowBe4 IPO. This company provides a platform for cyber attack protection and social engineering. In particular, it teaches enterprise employees to detect cyber threats through phishing modeling. In 2020, Forrester Wave named KnowBe4 a leader among the top 12 information security and employee training companies. You can apply to trade KnowBe4 IPO until today, 7:00 pm UTC+2.
Learn More about KnowBe4 IPO >>
I also applied to trade KnowBe4 with a $2,000 stake. My client rating went up again, but the overall score is still 2/5.
Meanwhile, the Portfolio Liquidity score rose to 4/5, most likely because I bought two Coinbase shares recently:
Today is also the last day to trade Zymergen IPO. Zymergen creates optic films and other coverings for consumer electronics, based on synthetic biology; besides, it also develops insect repellents.
Learn More about Zymergen IPO >>
I am applying to trade Zymergen with a $2,000 stake, too; I am always putting the same amount in order to boost my rating:
Previous IPO allocation and first trade results
Akoya Biosciences (AKYA)
Order amount: $2,000
Price: $20 per share
Allocation rating: 2/5
Allocation: 2 shares at $40 (2% of the order amount)
On the first trading day, April 16, Akoya stock grew up by 30 % to reach $26 per share, the profit being $12.
Recursion Pharmaceuticals (RXRX)
Order amount: $2,000
Price: $18 per share
Allocation rating: 2/5
Allocation: 3 shares at $54 (2.7% of the order amount)
On the first trading day, April 16, stock soared by +66.7% to reach $30 per share, the profit being $36.
That is it for now. Stay tuned!
